SecProbe.io

Filing text and metadata
Intelligence Terminal Search Probe Scores Topics IPO Watchlist Monthly Activity About API

SEC Comment Letter for BIOMARIN PHARMACEUTICAL INC (BMRN) (CIK 0001048477) (BMRN) — Nov 6, 2008

BIOMARIN PHARMACEUTICAL INC (BMRN) (CIK 0001048477)
Date: Nov. 6, 2008 · CIK: 0001048477 · Accession: 0000000000-08-055319

View on Edgar

AI Filing Summary & Sentiment

Sentiment
Urgency
Document Type
Confidence
SEC Posture
Company Posture

Summary

Reasoning

Date
November 6, 2008
Author
Gustavo A. Rodriguez
Form
UPLOAD
Company
BIOMARIN PHARMACEUTICAL INC (BMRN) (CIK 0001048477)

Letter

Via Facsimile and U.S. Mail Mail Stop 6010 November 6, 2008 Mr. Jeffrey H. Cooper Senior Vice President, Chief Financial Officer BioMarin Pharmaceutical Inc. 105 Digital Drive Novato, CA 94949

Re: BioMarin Pharmaceutical Inc. Form 10-K for the Fiscal Year Ended December 31, 2007 File No. 0-26727

Dear Mr. Cooper: We have completed our review of your Form 10-K and have no further comments at this time. Sincerely,

Gustavo A. Rodriguez Branch Chief

Show Raw Text 
Via Facsimile and U.S. Mail Mail Stop 6010         November 6, 2008
Mr. Jeffrey H. Cooper
Senior Vice President, Chief Financial Officer
BioMarin Pharmaceutical Inc. 105 Digital Drive
Novato, CA  94949

Re: BioMarin Pharmaceutical Inc.
 Form 10-K for the Fiscal Year Ended December 31, 2007
 File No. 0-26727

Dear Mr. Cooper:
 We have completed our review of your Form 10-K and have no further comments
at this time.
Sincerely,

Gustavo A. Rodriguez
Branch Chief

More SEC correspondence for this issuer

Continue through recent SEC comment letters and company responses for BIOMARIN PHARMACEUTICAL INC (BMRN) (CIK 0001048477) (BMRN).